Berkshire Hathaway Inc. New Common Stock Azioni (NYSE: BRK/B)

Ultime notizie per Berkshire Hathaway Inc. New Common Stock (NYSE:BRK/B) Azioni

Berkshire Hathaway Inc. New Common Stock

Berkshire Hathaway Inc

Infrared Cameras Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.02) by 1600 percent. This is a 90.23 percent increase over losses of $(3.48) per share from the same period last year. The company reported $1.60 million in sales this quarter. This is a 6.87 percent increase over sales of $1.50 million the same period last year.

Earnings

Earnings Misses

News

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

Infrared Cameras Holdings Q3 EPS $(0.34) Misses $(0.02) Estimate, Sales $1.60M Up From $1.50M YoY

Orla Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ORLA#AMEX">ORLA</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. The company reported quarterly sales of $99.31 million which beat the analyst consensus estimate of $80.39 million by 23.54 percent. This is a 64.70 percent increase over sales of $60.29 million the same period last year.

Earnings Beats

ORLA

Orla Mining Q3 2024 Adj EPS $0.06 Misses $0.08 Estimate, Sales $99.31M Beat $80.39M Estimate

NRDY

Nerdy Reveals Receipt Of Non-Compliance Notice From NYSE On November 12

Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.85) by 23.53 percent. This is a 53.9 percent increase over losses of $(1.41) per share from the same period last year.

CLDI

Calidi Biotherapeutics Q3 2024 GAAP EPS $(0.65) Beats $(0.85) Estimate

Occidental Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) reported its third-quarter results after Tuesday's closing bell. Here's a look at the key <a href="https://www.benzinga.com/pressreleases/24/11/g41919462/occidental-announces-third-quarter-2024-results">figures from the quarter. </a>
The Details:&nbsp;Occidental Petroleum reported quarterly adjusted earnings of $1.00 per share, beating the analyst consensus estimate of 74 cents. Quarterly revenue came in at $7.15 billion, missing the consensus estimate of $7.23 billion. 
<ul>
<li>Strong operational performance drove operating cash flow of $3.8 billion and operating cash flow before working capital of $3.1 billion.</li>
<li>Capital spending of $1.7 billion and contributions from noncontrolling interest of $47 million resulted in quarterly free cash flow before working capital of $1.5 billion.</li>
<li>Total company production of 1,412 Mboed exceeded the mid-point of guidance by 22 Mboed.</li>
<li>Midstream and marketing exceeded the mid-point of guidance for pre-tax adjusted income by $145 million.</li>
<li>OxyChem exceeded guidance with pre-tax income of $304 million.</li>
<li>Repaid $4 billion of debt, achieving nearly 90% of Occidental&#8217;s short-term debt reduction target.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/earnings/24/11/41914981/bitcoin-miners-hive-digital-hut-8-bitfarms-to-report-earnings-as-future-of-crypto-has-never-been-brighter">Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto &#8216;Has Never Been Brighter&#8217;</a>
&#8220;Strong operational performance across all segments has resulted in our highest quarterly operating cash flow this year,&#8221; said president and CEO Vicki Hollub. 
&#8220;The integration of CrownRock is off to a great start in terms of personnel and operations, and we have made significant progress in our deleveraging efforts, achieving nearly 90% of our short-term debt reduction target,&#8221; Hollub added. 
The company will host a conference call to discuss the results at 1 p.m. ET Wednesday.&nbsp;
OXY Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Occidental Petroleum shares are up 0.52% after-hours at $50.55 at the time of publication Tuesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Shutterstock

Commodities

After-Hours Center

Movers

Occidental Petroleum Shares Steady After Mixed Q3 Results

Oriental Culture Holding H1 EPS $(0.28) Up From $(0.50) YoY, Sales $0.447M Down From $0.799M YoY

Aris Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ARMN#AMEX">ARMN</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.14 by 42.86 percent. The company reported quarterly sales of $131.577 million which missed the analyst consensus estimate of $138.440 million by 4.96 percent. This is a 16.49 percent increase over sales of $112.955 million the same period last year.

ARMN

Aris Mining Q3 2024 Adj. EPS $0.08 Misses $0.14 Estimate, Sales $131.577M Miss $138.440M Estimate

Bolt Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLT#NASDAQ">BOLT</a>) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 14.29 percent. The company reported quarterly sales of $1.141 million which missed the analyst consensus estimate of $1.263 million by 9.64 percent. This is a 54.87 percent decrease over sales of $2.528 million the same period last year.

BOLT

Bolt Biotherapeutics Q3 2024 GAAP EPS $(0.40) Misses $(0.35) Estimate, Sales $1.141M Miss $1.263M Estimate

TERN

Terns Pharma Q3 EPS $(0.28) Beats $(0.34) Estimate

Guidance

GRDN

Guardian Pharmacy Services Sees FY24 Revenue $1.205B-$1.215B Vs $1.191B Estimate;  Sees Adj. EBITDA $86.5M-$87M

Guardian Pharmacy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRDN#NYSE">GRDN</a>) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $0.21 by 1052.38 percent. The company reported quarterly sales of $314.39 million which beat the analyst consensus estimate of $303.16 million by 3.71 percent. This is a 19.66 percent increase over sales of $262.74 million the same period last year.

Guardian Pharmacy Service Q3 2024 GAAP EPS $(2.00) Misses $0.21 Estimate, Sales $314.39M Beat $303.16M Estimate

Adams Resources &amp; Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AE#AMEX">AE</a>) reported quarterly losses of $(1.76) per share which missed the analyst consensus estimate of $(0.28) by 528.57 percent. The company reported quarterly sales of $695.163 million which beat the analyst consensus estimate of $654.996 million by 6.13 percent. This is a 8.61 percent decrease over sales of $760.614 million the same period last year.

Adams Resources & Energy Q3 2024 GAAP EPS $(1.76) Misses $(0.28) Estimate, Sales $695.163M Beat $654.996M Estimate

TeraWulf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) reported its third-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/g41918828/terawulf-reports-third-quarter-2024-financial-results">details from the report.&nbsp;&nbsp;</a>
The Details:&nbsp;TeraWulf reported quarterly GAAP losses of six cents per share, which missed the analyst consensus estimate for losses of three cents. Quarterly revenue came in at $27.05 million, which missed the analyst consensus estimate of $34.27 million and is an increase over sales of $18.95 million from the same period last year.
<ul>
<li>TeraWulf self-mined 555 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) across the Lake Mariner and Nautilus Cryptomine facilities, which represented a 43.4% decrease relative to the same quarter last year.</li>
<li>Total value of Bitcoin self-mined was $33.9 million compared to $27.6 million in the prior year&#8217;s quarter.</li>
<li>Power cost per Bitcoin self-mined increased year-over-year, to $30,448 per Bitcoin, up from $9,322 per Bitcoin in the third-quarter of 2023 due to an approximate doubling in network difficulty and the Bitcoin reward halving in April 2024.</li>
<li>Total self-mining hashrate capacity of 10.0 EH/s as of Sept. 30, 2024, represents an increase of 100% relative to the same prior year period.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/earnings/24/11/41914981/bitcoin-miners-hive-digital-hut-8-bitfarms-to-report-earnings-as-future-of-crypto-has-never-been-brighter">Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto &#8216;Has Never Been Brighter&#8217;</a>
&#8220;The third quarter and the beginning of the fourth quarter marked a pivotal turning point for TeraWulf, as we delivered strong results across our strategic, financial, and operational objectives,&#8221; said Paul Prager, chairman and CEO of TeraWulf.
&#8220;The sale of our interest in the Nautilus joint venture not only generated a substantial return but also sharpened our focus on scaling high-performance computing at Lake Mariner. Securing an expanded ground lease with exclusive rights to 750 MW of infrastructure capacity is a significant milestone in our growth strategy. Combined with the success of our $500 million capital raise, we are exceptionally well-positioned to seize new opportunities in both Bitcoin mining and HPC hosting as we enter 2025,&#8221; Prager added. 
WULF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, TeraWulf shares are down 3.51% after-hours at $8.23 at the time of publication Tuesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Photo: Pete Linforth from Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

WULF

TeraWulf Stock Tumbles After Worse-Than-Expected Q3 Results

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is unchanged from the same period last year. The company reported $7.92 million in sales this quarter. This is a 7.39 percent decrease over sales of $8.55 million the same period last year.

SunLink Health Systems Q1 EPS $(0.06), Same YoY, Sales $7.92M Down From $8.55M YoY

Cargo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) reported quarterly losses of $(0.88) per share which beat the analyst consensus estimate of $(1.15) by 23.48 percent. This is a 98.14 percent increase over losses of $(47.37) per share from the same period last year.

CRGX

Cargo Therapeutics Q3 EPS $(0.88) Beats $(1.15) Estimate

WIIM

Ginkgo Bioworks shares are trading higher after the company reported better-than-expected Q3 EPS and sales and raised its FY24 revenue guidance.

BioRestorative Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRTX#NASDAQ">BRTX</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.43) by 69.77 percent. This is a 133.33 percent decrease over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $233.60 thousand which missed the analyst consensus estimate of $350.00 thousand by 33.26 percent. This is a 660.91 percent increase over sales of $30.70 thousand the same period last year.

BRTX

BioRestorative Therapies Q3 EPS $(0.13) Beats $(0.43) Estimate, Sales $233.60K Miss $350.00K Estimate

Serina Therapeutics Q3 EPS $0.13 Down From $0.23 YoY, Sales $14K Down From $29K YoY

Psychemedics Q3 EPS $(0.09) Up From $(0.36) YoY, Sales $5.20M Down From $5.70M YoY

TherapeuticsMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXMD#NASDAQ">TXMD</a>) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year. The company reported $547.00 thousand in sales this quarter. This is a 1.13K percent increase over sales of $(53.00 thousand) the same period last year.

TXMD

TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Berkshire Hathaway Inc. New Common Stock (NYSE:<a href="https://investorplace.com/stock-quotes/brk-b-stock-quote/">BRK/B</a>) just reported results for the first quarter of 2024.<ul><li>Berkshire Hathaway Inc. New Common Stock reported earnings per share of $5.20. This was above the analyst estimate for EPS of $4.55.</li><li>The company reported revenue of $89.87 billion.</li><li>This was 3.25% better than the analyst estimate for revenue of $87.04 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/brk-b-stock-earnings-berkshire-hathaway-inc-new-common-stock-for-q1-of-2024/">BRK/B Stock Earnings: Berkshire Hathaway Inc. New Common Stock Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BRK/B Stock Earnings: Berkshire Hathaway Inc. New Common Stock Beats EPS, Beats Revenue for Q1 2024

BRK/B

Enact Holdings

Affirm Holdings, Inc. - Class A Common Stock

Affirm Holdings

Berkshire Hathaway Inc. Common Stock

Mr. Cooper Gr

Corpay

Corebridge Financial

Equitable Hldgs

Essent Group

Fiserv

Fidelity National Information Services, Inc. Common Stock

Fidelity National Info

Shift4 Payments, Inc. Class A Common Stock

Shift4 Payments

Global Payments

ORIX

Jack Henry & Associates, Inc. - Common Stock

Jack Henry & Associates

Jackson Financial Inc. Class A Common Stock

Jackson Finl

Mastercard

MGIC Investment

PennyMac Financial Services, Inc. Common Stock

PennyMac Financial Servs

PayPal Holdings

Radian Group

Block

Toast

Visa

Voya Financial

TD Cowen

Morgan Stanley

Berkshire Hathaway

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from these and its other operations over the years to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include five of Berkshire's largest noninsurance pretax earnings generators: Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis.

Comments

Berkshire Hathaway Inc. New Common Stock

Notizie

Ultime notizie per Berkshire Hathaway Inc. New Common Stock (NYSE:BRK/B) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO